1. Home
  2. BVN vs IMVT Comparison

BVN vs IMVT Comparison

Compare BVN & IMVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Buenaventura Mining Company Inc.

BVN

Buenaventura Mining Company Inc.

N/A

Current Price

$19.51

Market Cap

6.9B

ML Signal

N/A

Logo Immunovant Inc.

IMVT

Immunovant Inc.

N/A

Current Price

$31.78

Market Cap

6.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BVN
IMVT
Founded
1953
2018
Country
Peru
United States
Employees
N/A
N/A
Industry
Metal Mining
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.9B
6.3B
IPO Year
1997
2019

Fundamental Metrics

Financial Performance
Metric
BVN
IMVT
Price
$19.51
$31.78
Analyst Decision
Hold
Buy
Analyst Count
6
17
Target Price
$36.83
★ $48.63
AVG Volume (30 Days)
1.0M
★ 1.2M
Earning Date
10-29-2026
11-09-2026
Dividend Yield
★ 5.35%
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$30.16
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$21.78
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$21.21
$21.93
52 Week High
$44.67
$45.42

Technical Indicators

Market Signals
Indicator
BVN
IMVT
Relative Strength Index (RSI) 19.10 47.92
Support Level N/A $30.24
Resistance Level $36.50 $35.44
Average True Range (ATR) 1.21 1.63
MACD -0.61 0.11
Stochastic Oscillator 4.60 37.38

Price Performance

Historical Comparison
BVN
IMVT

About BVN Buenaventura Mining Company Inc.

Compania de Minas Buenaventura SAA is a Peruvian precious metals-producing company with experience in mine exploration, development, construction, and operation.

About IMVT Immunovant Inc.

Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. The Company operates in a single operating segment and has one reportable segment, which includes all activities related to the discovery, development and manufacturing of its product candidates.

Share on Social Networks: